A pragmatic randomized trial of mailed fecal immunochemical testing to increase colorectal cancer screening among low‐income and minoritized populations

Ejemplares similares

• Making the best use of quantitative fecal immunochemical test results in colorectal cancer screening
  por: Hermann Brenner, et al.
  Publicado: (2024)
• Comparative analysis of emergency department visits, hospitalizations, and mortality rates in colorectal cancer patients with positive fecal immunochemical test screening before and during the COVID‐19 pandemic
  por: Mitsuhiro Koseki, et al.
  Publicado: (2025)
• Risk of colorectal cancer among fecal immunochemical test‐positive individuals by timing of previous colonoscopy: A multicenter analysis
  por: Takuji Kawamura, et al.
  Publicado: (2024)
• A novel index combining fecal immunochemical test, DNA test, and age improves detection of advanced colorectal adenoma
  por: Yukari Inoue, et al.
  Publicado: (2024)
• Systematic scoping review: Use of the faecal immunochemical test residual buffer to enhance colorectal cancer screening
  por: Timothy McAuliffe, et al.
  Publicado: (2024)